University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
NCT Number: NCT00910364
The purpose of this pilot study is to assess the feasibility of determining the effects of a structured exercise program started two to four weeks after diagnosis of a first episode lower-extremity deep vein thrombosis (DVT) for a period of 12 weeks in reducing the incidence of post-thrombotic syndrome (PTS).
Looking for future studies?
Notify Me21 year–75 year
All sexes
Interventional
Not applicable
Oklahoma City, Oklahoma, 73104, United States
Deep Vein Thrombosis (DVT) affects nearly 300,000 people in the U.S. each year. DVT of the leg results in PTS in up to 65% of patients,despite receiving appropriate medical management with anticoagulant therapy.
PTS, caused by persistent venous outflow obstruction and venous valvular dysfunction, may result in symptoms of leg pain, swelling, heaviness and cramping especially with prolonged standing.
All eligible patients with documented first-episode DVT interested in participating will undergo medical screening and a screening treadmill test prior to enrollment between two and four weeks post DVT diagnosis. All patients will be provided and asked to wear class II (30 to 40mmHg) knee length compression hose daily during the entire trial.
The formal exercise training includes both a supervised walking program and a home-based walking program for 12 weeks with follow-up at 26 weeks. Blood tests will be taken to measure levels of indicators of inflammation at baseline, week 4, week 12, and week 26. The primary outcomes will be the feasibility of the exercise program and the incidence of post-thrombotic syndrome at 26 weeks.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exercise
Time frame: at 26 weeks
Time frame: at 12 weeks
University of Oklahoma
Other
EXPERT Trial: Exercise to Prevent Post-thrombotic Syndrome Elicited by Recent Thrombosis
Acronym: EXPERT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02108041
Blood Clots, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT07290608
Artificial Intelligence, Cardiovascular Diseases
São Paulo, Brazil
View Trial DetailsNCT00839163
Cardiovascular Diseases, Deep Vein Thrombosis
Sydney, New South Wales, Australia
View Trial DetailsNCT04373707
COVID, Cardiovascular Diseases
Amiens, France
View Trial Details